BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17591767)

  • 1. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.
    Askew EB; Gampe RT; Stanley TB; Faggart JL; Wilson EM
    J Biol Chem; 2007 Aug; 282(35):25801-16. PubMed ID: 17591767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
    Askew EB; Minges JT; Hnat AT; Wilson EM
    Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.
    Bai S; He B; Wilson EM
    Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of interdomain interactions of the androgen receptor.
    Wilson EM
    Methods Mol Biol; 2011; 776():113-29. PubMed ID: 21796524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
    He B; Kemppainen JA; Wilson EM
    J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
    He B; Wilson EM
    Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
    Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
    Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
    Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
    J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.
    Estébanez-Perpiñá E; Moore JM; Mar E; Delgado-Rodrigues E; Nguyen P; Baxter JD; Buehrer BM; Webb P; Fletterick RJ; Guy RK
    J Biol Chem; 2005 Mar; 280(9):8060-8. PubMed ID: 15563469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity.
    Pereira de Jésus-Tran K; Côté PL; Cantin L; Blanchet J; Labrie F; Breton R
    Protein Sci; 2006 May; 15(5):987-99. PubMed ID: 16641486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
    Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE
    J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ligand-dependent changes in AR structure using peptide probes.
    Chang CY; McDonnell DP
    Mol Endocrinol; 2002 Apr; 16(4):647-60. PubMed ID: 11923463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor.
    Bai S; Wilson EM
    Mol Cell Biol; 2008 Mar; 28(6):1947-63. PubMed ID: 18212060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations.
    Jin Y; Duan M; Wang X; Kong X; Zhou W; Sun H; Liu H; Li D; Yu H; Li Y; Hou T
    J Chem Inf Model; 2019 Feb; 59(2):842-857. PubMed ID: 30658039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FXXLF motif mediates androgen receptor-specific interactions with coregulators.
    He B; Minges JT; Lee LW; Wilson EM
    J Biol Chem; 2002 Mar; 277(12):10226-35. PubMed ID: 11779876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
    Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
    Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions.
    Duff J; McEwan IJ
    Mol Endocrinol; 2005 Dec; 19(12):2943-54. PubMed ID: 16081517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.